Effects and mechanisms of auricular vagus nerve stimulation on high-fat-diet-induced obese rats

Nutrition

Volumn 31, Issue 11-12, 2015, Pages 1416-1422

  Han, Li ^a,b   Jian Bin, Zhang ^c   Chen, Xu ^d   Qing Qing, Tang ^a   Wei Xing, Shen ^c   Jing Zhu, Zhou ^a   Jian De, Chen ^e   Yin Ping, Wang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^d Wujiang First Hospital   (China)

^e University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Auricular vagus nerve stimulation; Energy expenditure; Food intake; Metabolism; Obesity

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; BETA ACTIN; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; MESSENGER RNA; NORADRENALIN; PEPTIDE YY [3-36]; UNCOUPLING PROTEIN 1; FAT INTAKE; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AURICULAR VAGUS NERVE STIMULATION; BETA ACTIN GENE; BETA3 ADRENOCEPTOR GENE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CALORIC INTAKE; CCKA GENE; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD INTAKE; GENE; GENE EXPRESSION; HORMONE BLOOD LEVEL; ILEUM; LIPID DIET; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; OBESITY; PERIRENAL FAT; PRIORITY JOURNAL; PYY3 36 RECEPTOR GENE; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; STOMACH ANTRUM; STOMACH CONTENT; STOMACH EMPTYING; UCP1 GENE; VAGUS NERVE STIMULATION; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE; ADIPOSE TISSUE; ADMINISTRATION AND DOSAGE; ANIMAL; BLOOD; EAR; FAT INTAKE; INTRAABDOMINAL FAT; METABOLISM; PROCEDURES;

ADIPOSE TISSUE; ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; DIET, HIGH-FAT; DIETARY FATS; EAR; ENERGY INTAKE; ENERGY METABOLISM; INTRA-ABDOMINAL FAT; ION CHANNELS; MALE; MITOCHONDRIAL PROTEINS; NOREPINEPHRINE; OBESITY; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-3; VAGUS NERVE STIMULATION; WEIGHT LOSS;

EID: 84942320211     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2015.05.007     Document Type: Article

References (46)

1. Cannon B., Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev 2004, 84:277-359.
2. Allison D.B., Fontaine K.R., Manson J.E., Stevens J., VanItallie T.B. Annual deaths attributable to obesity in the United States. JAMA 1999, 282:1530-1538.
3. Finkelstein E.A., Trogdon J.G., Cohen J.W., Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) 2009, 28:w822-w831.
4. Adan R.A., Vanderschuren L.J., la Fleur S.E. Anti-obesity drugs and neural circuits of feeding. Trends Pharmacol Sci 2008, 29:208-217.
5. Stephens M., Ludgate M., Rees D.A. Brown fat and obesity: the next big thing?. Clin Endocrinol (Oxf) 2011, 74:661-670.
6. Said O., Saad B., Fulder S., Khalil K., Kassis E. Weight loss in animals and humans treated with "weighlevel." A combination of four medicinal plants used in traditional Arabic and Islamic medicine. Evid Based Complement Alternat Med 2011, 2011:874538.
7. Patwari P., Emilsson V., Schadt E.E., Chutkow W.A., Lee S., Marsili A., et al. The arrestin domain-containing 3 protein regulates body mass and energy expenditure. Cell Metab 2011, 14:671-683.
8. Haas B., Schlinkert P., Mayer P., Eckstein N. Targeting adipose tissue. Diabetol Metab Syndr 2012, 4:43.
9. Stefan H., Kreiselmeyer G., Kerling F., Kurzbuch K., Rauch C., Heers M., et al. Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial. Epilepsia 2012, 53:e115-e118.
10. Kraus T., Hosl K., Kiess O., Schanze A., Kornhuber J., Forster C. BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation. J Neural Transm 2007, 114:1485-1493.
11. Hamann J.J., Ruble S.B., Stolen C., Wang M., Gupta R.C., Rastogi S., et al. Vagus nerve stimulation improves left ventricular function in a canine model of chronic heart failure. Eur J Heart Fail 2013, 15:1319-1326.
12. Camilleri M., Toouli J., Herrera M.F., Kulseng B., Kow L., Pantoja J.P., et al. Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device. Surgery 2008, 143:723-731.
13. Camilleri M., Toouli J., Herrera M.F., Kow L., Pantoja J.P., Billington C.J., et al. Selection of electrical algorithms to treat obesity with intermittent vagal block using an implantable medical device. Surg Obes Relat Dis 2009, 5:224-229. discussion 9-30.
14. Gil K., Bugajski A., Thor P. Electrical vagus nerve stimulation decreases food consumption and weight gain in rats fed a high-fat diet. J Physiol Pharmacol 2011, 62:637-646.
15. Vijgen G.H., Bouvy N.D., Leenen L., Rijkers K., Cornips E., Majoie M., et al. Vagus nerve stimulation increases energy expenditure: relation to brown adipose tissue activity. PLoS One 2013, 8:e77221.
16. Balbo S.L., Grassiolli S., Ribeiro R.A., Bonfleur M.L., Gravena C., Brito Mdo N., et al. Fat storage is partially dependent on vagal activity and insulin secretion of hypothalamic obese rat. Endocrine 2007, 31:142-148.
17. Ventureyra E.C. Transcutaneous vagus nerve stimulation for partial onset seizure therapy. A new concept. Childs Nerv Syst 2000, 16:101-102.
18. Zhao Y.X., He W., Jing X.H., Liu J.L., Rong P.J., Ben H., et al. Transcutaneous auricular vagus nerve stimulation protects endotoxemic rat from lipopolysaccharide-induced inflammation. Evid Based Complement Alternat Med 2012, 2012:627023.
19. Peuker E.T., Filler T.J. The nerve supply of the human auricle. Clin Anat 2002, 15:35-37.
20. Cakmak Y.O. Epilepsy, electroacupuncture and the nucleus of the solitary tract. Acupunct Med 2006, 24:164-168.
21. Tubbs R.S., Salter E.G., Oakes W.J. Anatomic landmarks of the glossopharyngeal nerve: a microsurgical anatomic study. Neurosurgery 2004, 55:256.
22. Weijnen J.A., Surink S., Verstralen M.J., Moerkerken A., De Bree G.J., Bleys R.L. Main trajectories of nerves that traverse and surround the tympanic cavity in the rat. J Anat 2000, 197(Pt 2):247-262.
23. Xu J., McNearney T.A., Chen J.D. Impaired postprandial releases/syntheses of ghrelin and PYY(3-36) and blunted responses to exogenous ghrelin and PYY(3-36) in a rodent model of diet-induced obesity. J Gastroenterol Hepatol 2011, 26:700-705.
24. Iwa M., Nakade Y., Pappas T.N., Takahashi T. Electroacupuncture improves restraint stress-induced delay of gastric emptying via central glutaminergic pathways in conscious rats. Neurosci Lett 2006, 399:6-10.
25. Radahmadi M., Alaei H., Sharifi M.R., Hosseini N. The effect of synchronized running activity with chronic stress on passive avoidance learning and body weight in rats. Int J Prev Med 2013, 4:430-437.
26. Laskiewicz J., Krolczyk G., Zurowski G., Sobocki J., Matyja A., Thor P.J. Effects of vagal neuromodulation and vagotomy on control of food intake and body weight in rats. J Physiol Pharmacol 2003, 54:603-610.
27. de Lartigue G., Barbier de la Serre C., Espero E., Lee J., Raybould H.E. Diet-induced obesity leads to the development of leptin resistance in vagal afferent neurons. Am J Physiol Endocrinol Metab 2011, 301:E187-E195.
28. Heldsinger A., Lu Y., Zhou S.Y., Wu X., Grabauskas G., Song I., et al. Cocaine- and amphetamine-regulated transcript is the neurotransmitter regulating the action of cholecystokinin and leptin on short-term satiety in rats. Am J Physiol Gastrointest Liver Physiol 2012, 303:G1042-G1051.
29. Mello-Carpes P.B., Izquierdo I. The nucleus of the solitary tract → nucleus paragigantocellularis → locus coeruleus → CA1 region of dorsal hippocampus pathway is important for consolidation of object recognition memory. Neurobiol Learn Mem 2013, 100:56-63.
30. Shen E.Y., Hsieh C.L., Chang Y.H., Lin J.G. Observation of sympathomimetic effect of ear acupuncture stimulation for body weight reduction. Am J Chin Med 2009, 37:1023-1030.
31. Bartelt A., Bruns O.T., Reimer R., Hohenberg H., Ittrich H., Peldschus K., et al. Brown adipose tissue activity controls triglyceride clearance. Nat Med 2011, 17:200-205.
32. Satterfield M.C., Wu G. Brown adipose tissue growth and development: significance and nutritional regulation. Front Biosci (Landmark Ed) 2011, 16:1589-1608.
33. Sugimoto S., Nakajima H., Kodo K., Mori J., Matsuo K., Kosaka K., et al. Miglitol increases energy expenditure by upregulating uncoupling protein 1 of brown adipose tissue and reduces obesity in dietary-induced obese mice. Nutr Metab (Lond) 2014, 11:14.
34. Loyd C., Obici S. Brown fat fuel use and regulation of energy homeostasis. Curr Opin Clin Nutr Metab Care 2014, 17:368-372.
35. Bugajski A.J., Gil K., Ziomber A., Zurowski D., Zaraska W., Thor P.J. Effect of long-term vagal stimulation on food intake and body weight during diet induced obesity in rats. J Physiol Pharmacol 2007, 58(Suppl 1):5-12.
36. Ziomber A., Juszczak K., Kaszuba-Zwoinska J., Machowska A., Zaraska K., Gil K., et al. Magnetically induced vagus nerve stimulation and feeding behavior in rats. J Physiol Pharmacol 2009, 60:71-77.
37. He W., Wang X., Shi H., Shang H., Li L., Jing X., et al. Auricular acupuncture and vagal regulation. Evid Based Complement Alternat Med 2012, 2012:786839.
38. Irwin N., Frizelle P., Montgomery I.A., Moffett R.C., O'Harte F.P., Flatt P.R. Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes. Diabetologia 2012, 55:2747-2758.
39. Moran T.H., Bi S. Hyperphagia and obesity in OLETF rats lacking CCK-1 receptors. Philos Trans R Soc Lond B Biol Sci 2006, 361:1211-1218.
40. Adrian T.E., Savage A.P., Sagor G.R., Allen J.M., Bacarese-Hamilton A.J., Tatemoto K., et al. Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology 1985, 89:494-499.
41. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002, 418:650-654.
42. Batterham R.L., Cohen M.A., Ellis S.M., Le Roux C.W., Withers D.J., Frost G.S., et al. Inhibition of food intake in obese subjects by peptide YY3 to 36. N Engl J Med 2003, 349:941-948.
43. Boey D., Lin S., Karl T., Baldock P., Lee N., Enriquez R., et al. Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity. Diabetologia 2006, 49:1360-1370.
44. Pavliukova E.N., Kuz'michkina M.A., Afanas'ev S.A., Karpov R.S. Klin Med (Mosk) 2013, 91:27-32.
45. Yu L., Scherlag B.J., Li S., Fan Y., Dyer J., Male S., et al. Low-level transcutaneous electrical stimulation of the auricular branch of the vagus nerve: a noninvasive approach to treat the initial phase of atrial fibrillation. Heart Rhythm 2013, 10:428-435.
46. Laqua R., Leutzow B., Wendt M., Usichenko T. Transcutaneous vagal nerve stimulation may elicit anti- and pro-nociceptive effects under experimentally-induced pain-a crossover placebo-controlled investigation. Auton Neurosci 2014, 185:120-122.